Why the study?
Caveolin-1 has a central role in atherosclerosis with pro- or anti-atherogenic functions depending on cell type, prompting examination of its role in regulating LDL fate in endothelial cells.
Caveolin-1 plays a critical, cell-specific role in the pathogenesis of atherosclerosis, notably by regulating LDL transport and fate in endothelial cells.
Caveolin-1 modulation may refine atherosclerosis models; leaves open clinical translation pending prospective trials.
Caveolae are 50-100 nm cell surface plasma membrane invaginations observed in terminally differentiated cells. They are characterized by the presence of the protein marker caveolin-1. Caveolae and caveolin-1 are involved in regulating several signal transduction pathways and processes. It is well recognized that they have a central role as regulators of atherosclerosis. Caveolin-1 and caveolae are present in most of the cells involved in the development of atherosclerosis, including endothelial cells, macrophages, and smooth muscle cells, with evidence of either pro- or anti-atherogenic functions depending on the cell type examined. Here, we focused on the role of caveolin-1 in the regulation of the LDLs' fate in endothelial cells.
No takes yet. Share an insight, caveat, or question.
Puddu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: